1707P CureCancer digital tool in the routine clinical oncology practice facilitates PROs, communicating with HCPs, treatment adherence and “distancing interventions” during COVID-19 and reduces costs: A feasibility and satisfaction study

Galiti, Dimitra; Agelaki, Sofia; Karampeazis, Athanasios; Linardou, Helena; Tsoukalas, Nikolaos; Arvanitou, Eleni; Georgopoulou, E.; Vallilas, Christos; Syrigos, Konstantinos; Sgourou, Stavroula; Kokkali-Zervos, S.; Stamatogianni, E.; Boutis, Anastasios; Christopoulou, Athina; Kontovinis, Loukas; Mala, Anjani; Rigas, George; Saridaki-Zoras, Z.; Nicolatou‐Galitis, Ourania; Boukovinas, Ioannis

doi:10.1016/j.annonc.2020.08.1771

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A higher education level was also related to higher acceptability of the digital solutions by other investigators [16][17][18][19]. Furthermore, in our study, the percentage of the University graduates was reduced at the completion of the study, compared to the one assessed 5 months after the initiation of the study (56% versus 61%), while the High School graduates were increased (30.75 % vs 23%) indicating a push to internet literacy due to the urgent need for digital solutions as a result of social distancing, related to the COVID-19 pandemic [20].…”

Section: Discussing the Patient-reported Pro Le Cancer Status And Socioeconomic Detailscontrasting

confidence: 61%

CureCancer Digital Platform In The Routine Clinical Oncology Practice Facilitates Patients’ Self-Data Recording, Communicating With Health Care Professionals, Treatment Adherence And “Distancing Interventions” During Covid-19 And Reduces Costs. A Feasibility And Satisfaction Study*.

Galiti¹,

Linardou

Agelaki

et al. 2021

Preprint

View full text Add to dashboard Cite

Purpose: We assessed CureCancer’s feasibility and patients’ and HCPs’ satisfaction. CureCancer is a patient-centric/driven platform, which enables patients to self-create their profile, report symptoms and communicate with physicians.Methods: Patients from 18 Centers were asked to register at CureCancer, upload their data and complete a questionnaire on demographics, disease and treatment characteristics, and their satisfaction. Results: 159 patients were enrolled and 144 (90.6%) registered. 114 of 144 (79.1%), 63 males and 51 females, median age 54.5 years, completed the questionnaire. 64 patients were University and 35 were high School graduates. 46 patients had metastatic disease, 87 were on active treatment and 51 received supportive care. All patients also visited non-oncology HCPs. Nineteen patients changed work status and 49 had children below 24 years. Registration was “very/very much” easy for 98 (86.0 %) patients. File uploading was “very/very much” easy for 47 (41.2%) patients. Over 80% of patients and physicians preferred the digital way. 99 patients and all HCPs will recommend CureCancer to others. Easy data access, improved communication, feeling safe, treatment adherence, interventions from distance, particularly during covid-19 pandemic and saving time and money, were highly commented by patients and HCPs. Conclusion: CureCancer was feasible and patients and HCPs were satisfied. File uploading changed to become more user friendly. Integration of CureCancer in the routine practice is expected to improve cancer care and reduce cancer costs. Patients’ self-reporting, with CureCancer, can increase the accuracy of clinical trial results and map social/work/economic issues following cancer diagnosis to assist health care policy.

show abstract

Section: Discussing the Patient-reported Pro Le Cancer Status And Socioeconomic Detailscontrasting

confidence: 61%

CureCancer Digital Platform In The Routine Clinical Oncology Practice Facilitates Patients’ Self-Data Recording, Communicating With Health Care Professionals, Treatment Adherence And “Distancing Interventions” During Covid-19 And Reduces Costs. A Feasibility And Satisfaction Study*.

Galiti¹,

Linardou

Agelaki

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…Most participants, in the present study, were University and High School graduates, indicating an association between younger age and digital solutions.A higher education level was also related to higher acceptability of the digital solutions by other investigators [16][17][18][19]. Furthermore, in our study, the percentage of the University graduates was reduced at the completion of the study, compared to the one assessed 5 months after the initiation of the study (56% versus 61%), while the High School graduates were increased (30.75 % vs 23%) indicating a push to internet literacy due to the urgent need for digital solutions because ofsocial distancing, relatedto the COVID-19 pandemic [20].…”

Section: Discussing the Patient-reportedpro Le Cancer Status And Soci...mentioning

confidence: 59%

CureCancer Digital Platform in Clinical Oncology Practice Facilitates Patients’ Self-data Recording, Communicating, Treatment Adherence, “Distancing Interventions” During Covid-19 and Reduces Costs. A Feasibility and Satisfaction Study.

Galiti¹,

Linardou

Agelaki

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: Globally 43.8 million people live with cancer. A 60% increase of cancer cases is estimated by 2040, with 29.4 million patients per year requiring therapy. Optimization of cancer management, using digital innovation, is urgently needed. CureCancer is a patient-centric/driven platform, which enables patients to self-create their profile, report symptoms, and communicate with physicians. We assessed CureCancer’s feasibility and patients’ and HCPs’ satisfaction. Methods: Patients from 9 Centers were asked to register at CureCancer, upload their data and complete a questionnaire on demographics, disease and treatment characteristics, and their satisfaction. Results: 159 patients were enrolled and 144 (90.6%) registered. 114 of 144 (79.1%), 63 males and 51 females, median age 54.5 years, completed the questionnaire. 64 patients were University and 35 were high School graduates. 46 patients had metastatic disease, 87 were on active treatment and 51 received supportive care. All patients also visited non-oncology HCPs. Nineteen patients changed work status and 49 had children below 24 years. Registration was “very/very much” easy for 98 (86.0 %) patients. File uploading was “very/very much” easy for 47 (41.2%) patients. Over 80% of patients and physicians preferred the digital way. 99 patients and all HCPs will recommend CureCancer to others. Easy data access, improved communication, feeling safe, treatment adherence, interventions from distance, particularly during covid-19 pandemic and saving time and money, were highly commented by patients and HCPs. Conclusion: CureCancer was feasible, and patients and HCPs were satisfied. Patients were successful to report information on their demographics, disease and treatment characteristics. They also disclosed the need to visit non-oncology HCPs during their cancer treatment and other socioeconomic issues. Integration of CureCancer in the routine practice is expected to improve cancer care and reduce cancer costs. Patients’ self-reporting, with CureCancer, can increase the accuracy of clinical trial results and map social/work/economic issues following cancer diagnosis to assist health care policy.

show abstract

1707P CureCancer digital tool in the routine clinical oncology practice facilitates PROs, communicating with HCPs, treatment adherence and “distancing interventions” during COVID-19 and reduces costs: A feasibility and satisfaction study

Cited by 2 publications

References 0 publications

CureCancer Digital Platform In The Routine Clinical Oncology Practice Facilitates Patients’ Self-Data Recording, Communicating With Health Care Professionals, Treatment Adherence And “Distancing Interventions” During Covid-19 And Reduces Costs. A Feasibility And Satisfaction Study*.

CureCancer Digital Platform In The Routine Clinical Oncology Practice Facilitates Patients’ Self-Data Recording, Communicating With Health Care Professionals, Treatment Adherence And “Distancing Interventions” During Covid-19 And Reduces Costs. A Feasibility And Satisfaction Study*.

CureCancer Digital Platform in Clinical Oncology Practice Facilitates Patients’ Self-data Recording, Communicating, Treatment Adherence, “Distancing Interventions” During Covid-19 and Reduces Costs. A Feasibility and Satisfaction Study.

Contact Info

Product

Resources

About